Richard Barry - 03 Nov 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for Richard Barry
Issuer symbol: SRPT
Transactions as of: 03 Nov 2023
Net transactions value: +$3,940,500
Form type: 4
Filing time: 06 Nov 2023, 08:00:11 UTC
Previous filing: 23 Aug 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Purchase	$788,100	+10,000		$78.81	10,000	03 Nov 2023	By LLC	F1
transaction	SRPT	Common Stock	Purchase	$3,152,400	+40,000	+40%	$78.81	140,000	03 Nov 2023	By Trust	F1
holding	SRPT	Common Stock						2,929,842	03 Nov 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.58 to $78.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.58 to $78.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.